The Cancer Consortium

Cancer News & Information Center

Tuesday, October 13th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

PreMD Inks Licensing Deal with AstraZeneca

By Global Cancer Consortium on July 16, 2007 • ( Leave a comment )

PreMD, a Toronto-based company that makes heart-disease and cancer screening tests, has signed a licensing agreement with big pharma for what’s being touted as the world’s first test to use skin cholesterol […]

Changes at Oncologix Reflect Med Tech Focus

By Global Cancer Consortium on July 3, 2007 • ( 1 Comment )

Oncologix Tech, a former long-distance phone company that in January sold off its primary assets to focus exclusively on its medical device subsidiary, has taken steps to further its commitment to the […]

Strong Showing of Healthcare Firms on FSB 100

By Global Cancer Consortium on June 29, 2007 • ( 1 Comment )

Fortune Small Business is out with its annual FSB 100, a list of the most successful small public companies in the U.S. Almost a quarter of the list (21 companies) is made […]

North Carolina Firm Puts New Twist on Brachytherapy

By Global Cancer Consortium on June 27, 2007 • ( Leave a comment )

CivaTech Oncology, a startup based in Research Triangle Park, NC, that’s developing a device for delivering more consistent radiation to prostate-cancer patients, has raised $800,000 in an oversubscribed private financing. The funding […]

Cytori Forgoes Drugs for Devices

By Global Cancer Consortium on June 27, 2007 • ( Leave a comment )

Cytori Therapeutics may be on to something. The San Diego firm is using stem and regenerative cell therapies to develop products for treating cardiovascular disease and performing reconstructive surgery. But unlike so […]

Molecular Diagnostics Have Edge in Med Tech Sector

By Global Cancer Consortium on June 20, 2007 • ( Leave a comment )

Companies developing molecular and specialty diagnostics are poised to outperform other sectors of medical technology in the coming years, according to an article that ran over the weekend in the Milwaukee Journal […]

Seeking Partners for Melanoma-Detection Device

By Global Cancer Consortium on June 19, 2007 • ( 2 Comments )

With its final pivotal trial moving along as planned, Irvington, NY-based Electro-Optical Sciences is actively initiating partnering discussions for its point-of-case melanoma-detection device. MelaFind is a handheld imaging device that emits 10 […]

Intuitive Inks Deal for New Position-Tracking System

By Global Cancer Consortium on June 14, 2007 • ( Leave a comment )

Sunnyvale, CA-based Intuitive Surgical has signed a deal with Luna Innovations, of Roanoke, VA, whereby Luna will supply its shape-sensing and position-tracking system for integration into Intuitive’s products, including the popular da […]

Posts navigation

‹ Newer 1 … 77 78 79 80 81 82 83 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.